GlassScriptPhysician profile
Brian J Marien
NPI 1306894415
$2,403.34
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $536 · 2020: $443 · 2021: $515 · 2022: $534 · 2023: $217 · 2024: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $375.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,311.83 | 2019-2024 | Xarelto |
| Smith+Nephew, INC. | $320.53 | 2019-2022 | |
| Organogenesis INC. | $237.07 | 2020-2024 | Puraply |
| Endologix LLC | $149.61 | 2019-2021 | |
| Tactile Systems Technology INC | $74.15 | 2019-2020 | |
| Boston Scientific Corporation | $68.21 | 2021-2023 | Varithena Administration Pack |
| Allergan, INC. | $67.63 | 2019-2022 | |
| Misonix INC | $35.15 | 2021 | |
| Medtronic, INC. | $32.49 | 2022-2024 | Venaseal |
| Inari Medical, INC. | $23.12 | 2021 | |
| Alexion Pharmaceuticals, INC. | $22.00 | 2022 | |
| Abbvie INC. | $16.82 | 2023 | |
| Davol INC. | $16.73 | 2020 | |
| Covidien LP | $14.60 | 2019 | |
| Terumo Medical Corporation | $13.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Marien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.